Telmisartan Attenuates Colon Inflammation, Oxidative Perturbations and Apoptosis in a Rat Model of Experimental Inflammatory Bowel Disease

Open Access

Peer-reviewed

Research Article

Hany H. Arab ,

* E-mail: hany.arab@pharma.cu.edu.eg

Affiliation Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt
⨯
Muhammad Y. Al-Shorbagy,

Affiliation Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
⨯
Dalaal M. Abdallah,

Affiliation Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
⨯
Noha N. Nassar

Affiliation Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
⨯

Reader Comments (0)

Colon
Is the Subject Area "Colon" applicable to this article?

Thanks for your feedback.
Colitis
Is the Subject Area "Colitis" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Antioxidants
Is the Subject Area "Antioxidants" applicable to this article?

Thanks for your feedback.
Inflammatory bowel disease
Is the Subject Area "Inflammatory bowel disease" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.